Best Hospitals for Blepharoplasty (Eyelid Surgery) in Dubai, UAE

The all-inclusive cost of blepharoplasty at GAF Healthcare partner hospitals ranges from approximately USD 800 to USD 2,500 in India, and from USD 2,000 to USD 5,500 in the UAE (Dubai or Abu Dhabi). These figures encompass surgeon fees, anaesthesia, operating theatre and facility charges, standard post-operative medications (antibiotic-steroid eye drops, lubricants, and oral analgesia), and follow-up consultations during the in-country stay. India's cost advantage — typically 40–60% lower than the UAE — reflects lower hospital overheads and operating costs rather than any difference in surgical expertise or safety standards; both destinations feature fellowship-trained oculoplastic or aesthetic plastic surgeons operating in NABH/JCI-accredited facilities (India) and JCI/DHA-licensed hospitals (UAE). The specific final cost depends on the scope of surgery: upper blepharoplasty alone (single lid pair) sits at the lower end, while combined four-lid blepharoplasty with concurrent levator advancement, fat repositioning, or canthopexy approaches the upper end of the range. Additional costs to budget for include international flights, accommodation (USD 30–200/night depending on destination and standard), and incidental expenses. GAF Healthcare provides a fully itemised cost estimate before any commitment is made.

Most patients require a minimum in-country stay of 10–14 days before they receive surgical clearance to take an international flight, making a total trip of approximately 1–2 weeks the standard planning benchmark. The fit-to-fly assessment, conducted by the operating surgeon at Day 10–14, evaluates five specific criteria: absence of active wound dehiscence or infection, no corneal epithelial compromise on slit-lamp examination with fluorescein staining, intraocular pressure within the normal range, ecchymosis (bruising) and oedema sufficiently resolved that the patient can comfortably open and close both eyes, and patient competency in self-administering prescribed eye drops independently. Assuming all criteria are met, a formal medical discharge summary and a written aftercare protocol for the patient's treating ophthalmologist at home are provided. Patients flying for more than 4 hours should use preservative-free artificial tear drops (e.g., sodium hyaluronate 0.2%) every 60–90 minutes during the flight to counteract the low cabin humidity (typically 10–20% relative humidity), wear UV-protective wrap-around sunglasses, and avoid rubbing or pressing on the operated eyelids. Patients who have undergone concurrent levator advancement or canthopexy may be advised to extend their in-country stay to 14–21 days to allow more complete soft-tissue healing and confirm stable eyelid positioning before the flight. GAF Healthcare's clinical team will communicate the expected stay duration precisely during the pre-travel teleconsultation.

Blepharoplasty performed by fellowship-trained oculoplastic or aesthetic plastic surgeons in accredited facilities achieves a clinical success rate of 95–98%, reflecting the high proportion of patients who achieve their primary functional or cosmetic objective without requiring revision surgery. For functional upper blepharoplasty — procedures indicated by documented superior visual field loss on Humphrey perimetry — outcome studies consistently report a ≥30% improvement in superior visual field and resolution of brow-strain headaches in over 95% of cases. For cosmetic blepharoplasty, patient satisfaction scores (measured by validated tools such as the FACE-Q Appearance-related Psychosocial Distress Scale and the Blepharoplasty Outcomes Evaluation questionnaire) exceed 90% at 12-month follow-up in high-volume centres. The most common reason for revision (occurring in approximately 2–4% of cases) is mild asymmetry, residual skin redundancy, or inadequate fat reduction — all of which are amenable to minor secondary procedures under local anaesthesia. Serious complications such as vision loss or severe corneal exposure are exceedingly rare (<0.1%) when surgery is performed following rigorous pre-operative screening (Schirmer's test, snap test, Bell's phenomenon assessment) and conservative tissue excision principles. The long-term durability of results is excellent: upper eyelid skin excision results are effectively permanent, as skin does not regenerate; lower lid fat repositioning typically maintains its result for 7–15 years. GAF Healthcare partner surgeons track their individual outcomes data and are able to share procedure-specific revision and complication rates during the initial consultation.